MedicaidCoverageMedium impact
2025.31 - Provider Bulletin - Updated Diagnosis Requirement for GLP-1 Agonist Medications and New Coverage of FDA Approved Weight Loss Drug Phentermine and Orlistat
Connecticut Medicaid (HUSKY Health)·CT · Family Medicine, Internal Medicine, Endocrinology +1 more·Pharmacy
Effective date
Jul 1, 2025
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid (HUSKY) extends coverage for GLP-1 diabetes medications used for other indications through July 31, 2025, and adds new coverage for oral weight loss medications orlistat and phentermine starting July 1, 2025. This affects pharmacy billing for Connecticut Medicaid members only.
Action Required
By July 1, 2025: Billing team must update pharmacy billing system to include coverage for orlistat and phentermine for Connecticut HUSKY A, B, C, and D members. Verify GLP-1 medication claims continue processing through July 31, 2025 for non-diabetes indications. Reference Provider Bulletin 2024-66 for complete billing guidelines.